LH — Labcorp Holdings Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $366.57
- YTD price return
- +46.11%
- YTD total return
- +47.20%
- Market cap
- 29.8B
- Enterprise value
- 36.3B
- Shares outstanding
- 81.2M
- 52W low
- $244.52
- 52W high
- $373.34
- From 52W high
- -1.81%
- From 52W low
- +49.91%
- 52W range
- 95%$245–$373
- Beta
- 0.87
Volume
- Rel volume
- 0.78×
- 30D volume
- 732.6K
- 30D $ vol
- 243.9M
Insider trading
- Insider net 1W
- −$108K
- Insider net 1M
- −$498K
- Insider net 3M
- −$2.9M
- Insider net 1Y
- −$10.9M
Form 4 transactions by trade date, as filed; latest on file 2026-11-03.
Fundamentals
- Sales (ttm)
- 14.6B
- Sales/share
- $179.74
- EPS (ttm)
- $12.18
- FCF (ttm)
- 1.3B
- FCF/share
- $15.85
- Book value/share
- $108.96
- Net margin
- 6.88%
- ROE
- 11.35%
- ROA
- 5.31%
- Debt / equity
- 0.59×
- Current ratio
- 1.41
Growth (CAGR, ttm) · 10Y
- Sales
- +6.03%+6.86%-2.49%+4.62%
- Net income
- +17.41%+37.55%-18.33%+4.32%
- FCF
- -6.80%+15.11%-14.26%+4.59%
- Shares
- -2.05%-1.47%-3.23%-2.35%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +19.66%+40.64%-15.45%+6.78%
- Sales/share
- +8.25%+8.23%+0.77%+7.13%
- FCF/share
- -4.85%+16.59%-11.39%+7.10%
- Book value/share
- +3.87%+5.52%-0.18%+7.35%
- Dividend/share
- +0.00%-14.27%n/an/a
- Price
- +48.67%+20.49%+9.19%+13.34%
- Total return
- +50.17%+21.90%+10.36%+13.95%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 30.1×
- P/OI (ttm)
- 19.8×
- Fwd P/E
- 18.8×
- P/S (ttm)
- 2.0×
- P/B (mrq)
- 3.4×
- P/FCF (ttm)
- 23.1×
- EV/EBITDA (fy)
- 16.4×
- EV/Sales (ttm)
- 2.5×
- FCF yield (ttm)
- 4.32%
- Dividend yield (fwd)Div yield
- 0.79%
- Dividend yield (ttm)
- 0.79%
- Dividend/share (fwd)
- $2.88
- Buyback yield (realized, 1y)
- 2.05%
- Shareholder yield (realized, 1y)
- 3.05%
- Buyback yield (cash, ttm)
- 2.27%
- Shareholder yield (cash, ttm)
- 3.07%
Vs own 10Y history
- P/E
- 81st
- P/OI
- 88th
- P/S
- 100th
- P/B
- 100th
- P/FCF
- 95th
Bar = where today’s multiple sits in LH’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-06#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR −10.8%10Y CAGR +3.3%YoY +1.4%EPS (diluted)
5Y CAGR −8.0%10Y CAGR +9.2%YoY +3.2%Free cash flow
5Y CAGR −7.2%10Y CAGR +5.2%YoY +47.0%TTM: operating cash flow $1.8B, capex −$528.1M
Q3 2026: operating cash flow $563.8M, capex −$151.6M
Shares (diluted)
5Y −14.5%10Y −16.7%YoY −2.5%Dividend per share
YoY +0.0%About Labcorp Holdings#
Data provided bySource: Twelve DataLabcorp Holdings Inc. is a global life sciences and healthcare company that provides laboratory services to support clinical care, research, and drug development. Labcorp Holdings Inc. serves doctors, hospitals, pharmaceutical companies, researchers, and patients through a broad portfolio that includes routine and specialty diagnostic testing, central laboratory services, and early development research support. Its Diagnostics Laboratories segment covers testing in areas such as oncology, women’s health, autoimmune disease, and neurology, while its Biopharma Laboratory Services segment supports pharmaceutical and biotech clients with laboratory capabilities for clinical trials and development programs. The company plays a key role in healthcare by helping customers generate data used in diagnosis, treatment decisions, and biomedical research.
Burlington, NC·71,000 employees·Diagnostics & Research·labcorp.com·As of Oct 28, 2026
Recent filings#
- Nov 48-K · Labcorp to Speak at the UBS Global Healthcare Conference
- Oct 30Insider sale · Parham Richelle P (Director) sold 1,078 shares for $389K at $361.22
- Oct 28Earnings · Earnings release — EPS $4.78 vs $4.65 est. (+2.8%); revenue $3.81B (+7% y/y) 8.8%
- Oct 218-K · Labcorp Declares Quarterly Dividend
- Sep 308-K · Labcorp to Announce Third Quarter Financial Results on October 28, 2026
ETFs holding LH#
33 of the 193 ETFs ChartRow carries live hold LH. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| SPLV | Invesco S&P 500 Low Volatility ETF | 0.9% |
| COWZ | Pacer US Cash Cows 100 ETF | 0.5% |
| XLV | Health Care Select Sector SPDR Fund | 0.4% |
| VOE | Vanguard Mid-Cap Value ETF | 0.4% |
| VHT | Vanguard Health Care ETF | 0.4% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.2% |
| RSP | Invesco S&P 500 Equal Weight ETF | 0.2% |
| VO | Vanguard Mid-Cap ETF | 0.2% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +16.98% | -0.79% |
| JNJ | Johnson & Johnson | +8.42% | +1.43% |
| ABBV | AbbVie Inc. | +9.23% | +1.07% |
| MRK | Merck & Co. Inc. | +3.37% | -0.14% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.74% | -0.40% |
| NVS | Novartis AG | +15.46% | +0.38% |
| TMO | Thermo Fisher Scientific Inc. | +5.81% | +2.63% |
| AMGN | Amgen Inc. | +14.36% | +0.03% |
